相关实验视频

Updated: May 10, 2025

Myo-mechanical Analysis of Isolated Skeletal Muscle

Myo-mechanical Analysis of Isolated Skeletal Muscle

Published on: February 22, 2011

德甲诱导的骨肌肉缩通过氨基酸复合物补充在老鼠减弱

So-Jung Lim^1,2, Hyun-Jin Kim¹, Hansik Kim³

¹Department of Pharmacology, College of Medicine, Hanyang University, Seoul 04763, Republic of Korea.

Life (Basel, Switzerland)

|April 26, 2025

概括

氨基酸复合物补充剂 (ACS) 有效地预防和治疗肌肉损失. 高剂量的ACS显著改善了肌肉质量,力量和运动能力,显示出肌肉损伤的明显恢复.

科学领域:

老年学是一门学科.
肌肉生理学肌肉生理学
营养生物化学营养生物化学

背景情况:

衰老导致肉症,肌肉缩的特征是由于不平衡的蛋白质合成和分解.
德克萨 (Dexa) 给药是一种常见的方法,可以在动物模型中诱导肉.
氨基酸复合物补充剂 (ACS) 正在研究其抵消肌肉损失的潜力.

研究的目的:

评估氨基酸复合物补充剂 (ACS) 在预防和治疗甲基 (Dexa) 诱导的小鼠肌肉缩的疗效.
为了确定ACS的最佳剂量和配方,用于治疗肉症.
评估ACS对肌肉质量,蛋白质含量,运动能力和肌肉组织完整性的影响.

主要方法:

斯普雷格·道利大鼠被分为七组,包括对照组和用德克萨和不同剂量/配方的ACS (100毫克,300毫克,500毫克或液体配方) 治疗的组.
补充剂和Dexa的服药是通过口服进行的,持续了4周.
使用跑步机测试 (TT) 和强迫游泳测试 (FST) 来测量运动能力.
分析了血液的生物化学指数,总肌肉蛋白和肌肉组织形态 (通过电子显微镜和H&E染色).

主要成果:

高剂量的ACS (500毫克) 显著增加了TT (110%的增长) 和FT的运动能力,与仅用Dexa治疗的老鼠相比.
所有ACS治疗组都显示了总肌肉蛋白的显著增加.
显微镜分析显示,高剂量的ACS在德克萨治疗的老鼠中保留了肌肉纤维结构,包括更清晰的M线和Z线以及部分完整的线粒体.

结论:

氨基酸复合物补充剂 (ACS) 有效地减轻了德克萨米他诱导的肉症大鼠模型中的肌肉损伤和损失.
高剂量的ACS在肌肉组织上表现出最显著的保护和恢复作用.
ACS治疗对血清指数,肌肉蛋白质质量和组织学完整性产生了积极影响,支持其治疗萨尔科佩尼亚的治疗潜力.

关键词:

这是一条M线的线路.这里是Z-line线.氨基酸复合物补充氨基酸复合物补充德克萨米他诱导的肉类.强制游泳测试强制游泳测试跑步机测试跑步机测试

更多相关视频

A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation

A Murine Model of Muscle Training by Neuromuscular Electrical Stimulation

Published on: May 9, 2012

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy

Published on: May 24, 2016

相关概念视频

Skeletal Muscle Relaxants: Adverse Effects

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Disorders of the Skeletal Muscle

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...